Top compounds associated with response to PRY


Feature Type Standardized
Nominal ANOVA
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.22 2e-05
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 7e-05
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.2 0.0001
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA PLX4720 CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA GDC-0879 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA PD318088 CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
Download CSV